When risk becomes illness: The personal and social consequences of cervical intraepithelial neoplasia medical surveillance

Carla Freijomil-Vázquez, Denise Gastaldo, Carmen Coronado, María-Jesús Movilla-Fernández, Carla Freijomil-Vázquez, Denise Gastaldo, Carmen Coronado, María-Jesús Movilla-Fernández

Abstract

Background: After the early detection of cervical intraepithelial neoplasia (CIN), medical surveillance of the precancerous lesions is carried out to control risk factors to avoid the development of cervical cancer.

Objective: To explore the effects of medical surveillance on the personal and social lives of women undergoing CIN follow-up and treatment.

Methodology: A generic qualitative study using a poststructuralist perspective of risk management was carried out in a gynecology clinic in a public hospital of the Galician Health Care System (Spain). Participants were selected through purposive sampling. The sample consisted of 21 women with a confirmed diagnosis of CIN. Semistructured interviews were recorded and transcribed, and a thematic analysis was carried out, including researcher triangulation to verify the results of the analysis.

Findings: Two main themes emerged from the participants' experiences: CIN medical surveillance encounters and risk management strategies are shaped by the biomedical discourse, and the effects of "risk treatment" for patients include (a) profound changes expected of patients, (b) increased patient risk management, and (c) resistance to risk management. While doctors' surveillance aimed to prevent the development of cervical cancer, women felt they were sick because they had to follow strict recommendations over an unspecified period of time and live with the possibility of a life-threatening disease. Clinical risk management resulted in the medicalization of women's personal and social lives and produced great uncertainty.

Conclusions: This study is the first to conceptualize CIN medical surveillance as an illness experience for patients. It also problematizes the effects of preventative practices in women's lives. Patients deal with great uncertainty, as CIN medical surveillance performed by gynecologists simultaneously trivializes the changes expected of patients and underestimates the effects of medical recommendations on patients' personal wellbeing and social relations.

Conflict of interest statement

The authors have declared that no competing interests exist.

References

    1. World Health Organization [Internet]. Human papillomavirus (HPV) and cervical cancer, Geneva: World Health Organization; 2019, [cited 2019 Jul 28]. Human papillomavirus (HPV) and cervical cancer; [about 10 screens]. Available from:
    1. De Martel C, Plummer M, Vignat J, Franceschi S. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer. 2017. August 15;141(4):664–670. 10.1002/ijc.30716
    1. Information Centre on HPV and Cancer. Human papillomavirus and related cancers, fact sheet 2018 [Internet]. Spain: Information Centre on HPV and Cancer; 2018. [cited 2019 Feb 13]. Available from:
    1. Ministerio de Sanidad, Consumo y Bienestar Social. Calendario común de vacunación a lo largo de toda la vida [Internet]. Spain: Ministerio de Sanidad, Consumo y Bienestar Social; 2019. [cited 2019 Aug 1]. Available from:
    1. Asociación Española de Patología Cervical y Colposcopia. Guía de cribado del cáncer de cuello de útero en España [Internet]. Spain: Asociación Española de Patología Cervical y Colposcopia; 2014. [cited 2019 Feb 10]. Available from:
    1. Royal Decree-Law No 1030/2006, which establishes the portfolio of common services of the Spanish National Health System and the procedure for its updating. Official State Gazette, No 222 (September 16, 2006)
    1. Asociación Española de Patología Cervical y Colposcopia. Prevención del cáncer de cuello de útero [Internet]. Spain: Asociación Española de Patología Cervical y Colposcopia; 2014. [cited 2019 Mar 23]. Available from:
    1. Falls RK. Spontaneous resolution rate of grade 1 cervical intraepithelial neoplasia in a private practice population. Am J Obstet Gynecol. 1999. August;181(2):278–82. 10.1016/s0002-9378(99)70548-x
    1. World Health Organization. WHO guidelines for treatment of cervical intraepithelial neoplasia 2–3 and adenocarcinoma in situ [Internet]. Geneva: World Health Organization; 2014. [cited 2019 Mar 23]. Available from:
    1. Roura E, Castellsagué X, Pawlita M, Travier N, Waterboer T, Margall N et al. Smoking as a major risk factor for cervical cancer and pre‐cancer: Results from the EPIC cohort. Int J Cancer. 2014. July 15;135(2):453–66. 10.1002/ijc.28666
    1. Asociación Española de Patología Cervical y Colposcopia. Métodos anticonceptivos, infección VPH, y lesiones premalignas de cuello uterino [Internet]. Spain: Asociación Española de Patología Cervical y Colposcopia; 2018. [cited 2018 Mar 22]. Available from:
    1. Asociación Española de Patología Cervical y Colposcopia. Vacunación selectiva frente al Virus del Papiloma Humano en poblaciones de riesgo elevado [Internet]. Spain: Asociación Española de Patología Cervical y Colposcopia; 2016. [cited 2019 Mar 22]. Available from:
    1. McRae J, Martin C, O’Leary J, Sharp L. “If you can’t treat HPV, why test for it?” Women’s attitudes to the changing face of cervical cancer prevention: a focus group study. BMC Women’s Health. 2014. May 6;14:64 10.1186/1472-6874-14-64
    1. Markovic-Denic L, Djuric O, Maksimovic N, Popovac S, Kesic V. Effects of Human Papillomavirus Awareness and Knowledge on Psychological State of Women Referred to Cervical Cancer Screening. J Low Genit Tract Di. 2018. July;22(3):178–183. 10.1097/LGT.0000000000000397
    1. O’Connor M, Costello L, Murphy J, Prendiville W, Martin CM, O’Leary J et al. Influences on human papillomavirus (HPV)-related information needs among women having HPV tests for follow-up of abnormal cervical cytology. J Fam Plann Reprod Health Care. 2015. April;41(2):134–41. 10.1136/jfprhc-2013-100750
    1. Mortensen LG, Adeler AL. Qualitative study of women’s anxiety and information needs after a diagnosis of cervical dysplasia. Z Gesundh Wiss. 2010. October;18(5):473–482. 10.1007/s10389-010-0330-1
    1. Castro-Vásquez MC, Arellano-Gálvez MC. [Access to information by women with HPV, cervical dysplasia and cancer in situ]. Salud Publica Mex. 2010. May-Jun;52(3):207–12. 10.1590/s0036-36342010000300004
    1. Fish LJ, Moorman P, Wordlaw-Stintson L, Vidal A, Smith JS, Hoyo C. Factors Associated With Adherence to Follow-up Colposcopy. Am J Health Educ. 2013;44:293–8. 10.1080/19325037.2013.838881
    1. Thangarajah F, Einzmann T, Bergauer F, Patzke J, Schmidt-Petruschkat S, Theune M et al. Cervical screening program and the psychological impact of an abnormal Pap smear: a self-assessment questionnaire study of 590 patients. Arch Gynecol Obstet. 2016. February;293(2):391–8. 10.1007/s00404-015-3821-z
    1. Arellano-Gálvez MC, Castro-Vásquez MC. [The stigma in women diagnosed with HPV, dysplasia and cervical cancer in Hermosillo, Sonora] Estud Soc. 2013;21(42):259–278.
    1. Cook C. The sexual health consultation as a moral occasion. Nurs Inq. 2014. March;21(1):11–9. 10.1111/nin.12018
    1. Oliveira de Melo R, Rocha-Moreira RC, Mendonça-Lopes RL. [Cervical cancer precursor lesions: significance for women in a referral center in Brazil] Revista de Pesquisa: Cuidado é fundamental online. 2015; 7(4): 3327–3338.
    1. De Melo Pessanha-Carvalho MC, Azevedo-Queiroz AB, Vasconcelos-Moura MA. Social images among women with precursory lesions of cervical cancer: study of social representations. Rev enferm UERJ [Internet]. 2014. [cited 2019 May 1]; 22(3): [about 10 p.]. Available from:
    1. Foucault M. The birth of the clinic. London: Routledge; 2003. [1963].
    1. Foucault M. The History of Sexuality Volume 1: An Introduction. London: Penguin Books; 1990. [1976].
    1. Gastaldo D. Is health education good for you? Re-thinking health education through the concept of bio-power In: Petersen A, Bunton R, editors. Foucault, Health and Medicine. London: Routledge; 1997, p. 113–133.
    1. Lupton D. Medicine as Culture: illness, disease and the body. 3rd ed SAGE; 2012.
    1. Rose N. The Politics of Life Itself. Princeton: Princeton University Press; 2007.
    1. Lupton D. Risk. 2nd ed New York: Routledge; 2013.
    1. Bover AB, Gastaldo D. [The centrality of the family as a resource for homecare: gender and generational perspectives]. Rev Bras Enferm. 2005;58:9–16. 10.1590/s0034-71672005000100002
    1. Nack A. From the patient's point of view: Practitioner interaction styles in the treatment of women with chronic STD In: Kronenfeld JJ, editor. Care for Major Health Problems and Population Health Concerns: Impacts on Patients, Providers and Policy. USA: Emerald Group Publishing Limited; 2008, p. 95–122.
    1. Connell E, Hunt A. The HPV vaccination campaign: A project of moral regulation in an era of biopolitics. Can J Sociol. 2010;35:63 10.29173/cjs6689
    1. Polzer J, Mancuso FV, Rudman DL. Risk, responsibility, resistance: Young women’s negotiations of identity and healthy citizenship in human papillomavirus (HPV) vaccination narratives. Narrat Inq. 2014;24:281–308. 10.1075/ni.24.2.06pol
    1. Rail G, Molino L, Fusco C, Norman ME, Petherick L, Polzer J et al. HPV vaccination discourses and the construction of “at-risk” girls. Can J Public Health. 2018;109:622–632. 10.17269/s41997-018-0108-8
    1. Mishra A, Graham JE. Risk, choice and the ‘girl vaccine’: Unpacking human papillomavirus (HPV) immunisation. Health Risk Soc. 2012;14:57–69. 10.1080/13698575.2011.641524
    1. Engels KS. Biopower, normalization, and HPV: A Foucauldian analysis of the HPV vaccine controversy. J Med Humanit. 2016. September;37(3):299–312. 10.1007/s10912-015-9361-5
    1. Burns K, Davies C. Constructions of young women’s health and wellbeing in neoliberal times: a case study of the HPV Vaccination Program in Australia In: Wright K, McLeod J, editors. Rethinking Youth Wellbeing. Springer, Singapore; 2015: p. 71–89
    1. Armstrong N. Resistance through risk: Women and cervical cancer screening. Health Risk Soc. 2005;7:161–176. 10.1080/13698570500108644
    1. Stagg-Taylor J. Australian pap smear registers and the creation of gendered identities. Griffith Law Review. 2013;22:504–531. 10.1080/10383441.2013.10854785
    1. Wyndham-West M, Durand N, Santoro A. Betwixt and Between Well and Sick in Cervical Precancer: Canadian Women’s Experiences of Recurring HPV Infections and HPV Vaccination. Can J Nurs Res. 2018. September;50(3):120–132. 10.1177/0844562118763496
    1. Caelli K., Ray L, Mill J. “Clear as mud”: Toward greater clarity in generic qualitative research. International Journal of Qualitative Methods. 2003;2(2):1–24. 10.1177/160940690300200201
    1. Ritchie J, Lewis J. Designing and selecting samples In: Ritchie J, Lewis J, editors. Qualitative Research Practice; A Guide for Social Science Students and Researchers. Sage, Los Angeles; 2003: p.77–104
    1. Malterud K, Siersma VD, Guassora AD. Sample size in qualitative interview studies: guided by information power. Qual Health Res. 2016. November;26(13):1753–1760. 10.1177/1049732315617444
    1. Thorne S. Interpretive description: Qualitative research for applied practice. 2nd ed New York: Routledge; 2016.
    1. Meyer S, Ward P. ‘How to’ use social theory within and throughout qualitative research in healthcare contexts. Sociology Compass. 2014. May;8(5):525–539. 10.1111/soc4.12155
    1. Guba E, Lincoln Y. Fourth Generation Evaluation. Newbury Park: Sage; 1989
    1. Authors (published article)
    1. Gifford SM. The meaning of lumps: a case study of the ambiguities of risk In: Janes CR, Stall R, Gifford SM, editors. Anthropology and epidemiology. Dordrecht: Springer; 1986, p. 213–246.
    1. Pessanha-Carvalho MC, Azevedo-Queiroz AB, Ferreira MDA. The social representations of women of reproductive age on cervical cancer precursor lesions. Texto & Contexto-Enfermagem. 2013;22:943–951. 10.1590/S0104-07072013000400010
    1. Hernández-Corrochano E. La maternidad después de…: Estudio etnográfico de la maternidad primípara tardía en España. Revista de Antropología Iberoamericana. 2016;11(1):79–103. 10.11156/aibr.110105
    1. Wang A, Cui G, Jin C, Wang Y, Tian X. Multicenter research on tumor and pregnancy outcomes in patients with early-stage cervical cancer after fertility-sparing surgery. J Int Med Res. 2019. July;47(7):2881–2889. 10.1177/0300060519845974
    1. Vitale SG, La Rosa VL, Rapisarda AMC, Laganà AS. The importance of fertility preservation counseling in patients with gynecologic cancer. J Reprod Infertil. 2017. Apr-Jun;18(2):261–263
    1. Valenti G, Vitale SG, Tropea A, Biondi A, Laganà AS. Tumor markers of uterine cervical cancer: a new scenario to guide surgical practice? Updates Surg. 2017. December;69(4):441–449. 10.1007/s13304-017-0491-3
    1. Nicol AF, de Andrade CV, Brusadelli MG, Lodin HM, Wells SI et al. The distribution of novel biomarkers in carcinoma-in-situ, microinvasive, and squamous cell carcinoma of the uterine cervix. Ann Diagn Pathol. 2019. February;38:115–122. 10.1016/j.anndiagpath.2018.12.001
    1. Lupton D. Perspectives on power, communication and the medical encounter: implications for nursing theory and practice. Nurs Inq. 1995. September;2(3):157–63. 10.1111/j.1440-1800.1995.tb00166.x
    1. Polzer J. Caring for the Self, Caring for Others: The Politics and Ethics of Generic Risk for Breast Cancer. Canadian woman studies, 2010;28(2):71–76
    1. Jiménez-Ruiz I, Moya-Nicolás M. [The family caregiver: the naturalized sense of obligation in women to be caregivers]. Enferm Glob. 2018;17(49):420–447. 10.6018/eglobal.17.1.292331
    1. Farrington EM, Bell DC, DiBacco AE. Reasons People Give for Using (or Not Using) Condoms. AIDS Behav. 2016. December;20(12):2850–2862. 10.1007/s10461-016-1352-7
    1. Bjekić M, Sipetić-Grujičić S, Vlajinac H, Nikolić A. Reasons for not using condoms among heterosexual men in Belgrade, Serbia. Acta Dermatovenerol Croat. 2018. April;26(1):58–60
    1. Cioe PA, Gordon RE, Guthrie KM, Freiberg MS, Kahler CW. Perceived barriers to smoking cessation and perceptions of electronic cigarettes among persons living with HIV. AIDS Care. 2018. November;30(11):1469–1475. 10.1080/09540121.2018.1489103
    1. Rzeszutek M. Health-related quality of life and coping strategies among people living with HIV: the moderating role of gender. Arch Womens Ment Health. 2018. June;21(3):247–257. 10.1007/s00737-017-0801-2

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir